MediFind found 6 doctor with experience in Chronic T-Cell Leukemia (CTCL) near Shimane, JP. Of these, 6 are Experienced.
Hayato Maruoka practices in Kobe, Japan. Mr. Maruoka is rated as an Experienced expert by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, Adult T-Cell Leukemia, and Bone Marrow Transplant.
Hiroshi Matsuoka practices in Kobe, Japan. Mr. Matsuoka is rated as an Experienced expert by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Splenic Neoplasm, Bone Marrow Transplant, and Bone Marrow Aspiration.
Takayuki Ishikawa practices in Kobe, Japan. Mr. Ishikawa is rated as an Experienced expert by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Myelodysplastic Syndrome (MDS), Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Gamma Knife Radiosurgery.
Tomohiro Kinoshita practices in Kakogawa, Japan. Mr. Kinoshita is rated as an Experienced expert by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Gastrectomy, and Gastrostomy.
Ryusuke Yamamoto practices in Kobe, Japan. Yamamoto is rated as an Experienced expert by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). Their top areas of expertise are Acute Erythroid Leukemia (AEL), Aplastic Anemia, Chronic Graft Versus Host Disease (cGvHD), Anemia, and Bone Marrow Transplant.
Nobuhiro Hiramoto practices in Kobe, Japan. Hiramoto is rated as an Experienced expert by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). Their top areas of expertise are Graft Versus Host Disease (GvHD), Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Graft.
To see more doctors, please expand your search radius or view related conditions below.
Last Updated: 01/09/2026